Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIAMCINOLONE Cause Peripheral venous disease? 144 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Peripheral venous disease have been filed in association with TRIAMCINOLONE. This represents 2.2% of all adverse event reports for TRIAMCINOLONE.

144
Reports of Peripheral venous disease with TRIAMCINOLONE
2.2%
of all TRIAMCINOLONE reports
143
Deaths
75
Hospitalizations

How Dangerous Is Peripheral venous disease From TRIAMCINOLONE?

Of the 144 reports, 143 (99.3%) resulted in death, 75 (52.1%) required hospitalization, and 78 (54.2%) were considered life-threatening.

Is Peripheral venous disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does TRIAMCINOLONE Cause?

Drug ineffective (3,035) Psoriasis (1,131) Off label use (901) Product use in unapproved indication (724) Condition aggravated (625) Therapeutic product effect incomplete (624) Treatment failure (612) Drug intolerance (527) Nausea (525) Pruritus (485)

What Other Drugs Cause Peripheral venous disease?

RITUXIMAB (1,281) ADALIMUMAB (1,249) METHOTREXATE (1,246) SECUKINUMAB (1,186) ABATACEPT (1,168) DICLOFENAC (1,168) LEFLUNOMIDE (1,154) TOCILIZUMAB (1,137) PREDNISONE (1,101) ALENDRONATE (1,097)

Which TRIAMCINOLONE Alternatives Have Lower Peripheral venous disease Risk?

TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE TRIAMCINOLONE vs TRIAMTERENE TRIAMCINOLONE vs TRIATEC TRIAMCINOLONE vs TRIAZOLAM

Related Pages

TRIAMCINOLONE Full Profile All Peripheral venous disease Reports All Drugs Causing Peripheral venous disease TRIAMCINOLONE Demographics